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Abstract
Objective To characterise symptoms experienced by women during the
transition into natural menopause, to classify women into distinct
symptom profiles or trajectories, and to relate these profiles to
sociodemographic factors and health behaviours.
Design Nationally representative cohort study.
Setting England, Scotland, and Wales.
Participants 695 women followed-up since birth in 1946 and annually
from age 47 to 54 who experienced natural menopause and reported
on 20 common health symptoms.
Main outcome measure Longitudinal profiles for reported bothersome
symptoms.
Results Of 20 individual symptoms, 18 formed into four stable symptom
groups: psychological, somatic, vasomotor, and sexual discomfort. Using
latent class analyses, all except the somatic group of symptoms showed
a clear relation with the timing of menopause for some women. A small
proportion of women (10%, n=63) had a severe psychological symptom
profile that peaked at or in the year after menopause. For vasomotor
symptoms, 14% of women (n=83) had the early severe profile that also
peaked around early postmenopause and then declined noticeably; 11%
(n=67) had the late severe profile of bothersome symptoms that
increased rapidly in perimenopause and remained high for four years
or more after menopause. Women were less likely to have a profile for
severe vasomotor symptoms if they were from a non-manual social class
(odds ratio 0.79, 95% confidence interval 0.57 to 1.01) or had degree
level qualifications (0.37, 0.18 to 0.77). The 14% of women (n=85) who
had the late severe profile for sexual discomfort showed a similar
increase in symptoms until menopause, with symptoms persisting after
menopause. Married women were more likely to have the late severe
or late moderate profile than women of other marital status (2.40, 1.30
to 4.41). Four profiles each were identified for somatic symptoms (mild,
moderate, severe, and very severe), although these did not vary by
chronological age or age at menopause.
Conclusion Profiles for psychological, vasomotor, and sexual discomfort
symptoms relative to age at menopause could help health professionals
to tailor their advice for women with natural menopause.
Introduction
Menopause, which marks the end of the reproductive phase of
awoman’slife,coincideswitharangeofsymptomsexperienced
during midlife. For some symptoms, such as hot flushes and
coldornightsweats(vasomotorsymptoms)andvaginaldryness,
the relation with menopausal transition is well established.
1 2
For other symptoms, such as headaches and joint pain, the
findings have been mixed.
3 Many studies have relied on cross
sectional data so that links with menopausal transition have
been difficult to disentangle from those due to ageing.
1 For all
symptoms little research has been done on whether subgroups
of women with similar longitudinal symptom profiles or
trajectories exist and how these relate to the timing of the
menopausal transition or change with age.
Understanding the course of vasomotor and other symptoms
through midlife and how they relate to the menopause would
help health professionals to inform women on the possible
duration and variation in severity of symptoms through the
menopausaltransition.Evenwithlongitudinalstudiestheresults
are often reported as mean prevalence of symptoms before and
after menopause across the sample, which may obscure the
underlying variability in scores across individual women and
across groups of women within a sample.
2 4-6
PreviousresearchusingdatafromtheMedicalResearchCouncil
NationalSurveyofHealthandDevelopment,apopulationbased
study,hasshownthatreportedhealthsymptomsatage47years
tend to cluster into vasomotor symptoms such as hot flushes
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Research
RESEARCHand cold night sweats, somatic symptoms such as headaches
and muscle and joint pain, and psychological symptoms such
as anxiety and depression.
7 We used longitudinal data from the
Medical Research Council’s survey to characterise the various
symptomsexperiencedbywomenwhohadanaturalmenopause
atage48to54.Weidentifiedgroupsofsymptomsthatcorrelate
over time, used latent class analysis to classify women into
distinct profiles or symptom trajectories through menopause
for each symptom group, and identified the links between
sociodemographic factors and health behaviours and the
symptom profiles.
Methods
The Medical Research Council National Survey of Health and
Development(alsoknownasthe1946Britishbirthcohortstudy)
is a longitudinal study of health based on a random sample of
5362 singleton births in England, Scotland, and Wales during
the first week of March 1946 and stratified on social class. A
total of 2547 women and 2815 men were followed up up to 22
times between birth and age 53 years. The cohort is still
generallyrepresentativeofthepopulationborninBritainatthat
time.
8From1993-2000,whencohortmemberswereaged47-54,
a postal questionnaire was sent annually to the 1778 (70%)
womenwithwhomtherewasthencontacttocollectinformation
on health symptoms, the menopause, and change in life
circumstances.
9 During this time a total of 1525 out of 1778
women (86%) completed at least one questionnaire, including
a checklist of health symptoms. This study focuses on the 695
women who were identified as having natural menopause and
who completed at least one questionnaire, with 675 women
having completed all seven questionnaires. We omitted from
these analyses those who had undergone hysterectomy or
received hormone treatment.
Results
Table 1⇓ provides descriptive statistics for the women with a
natural menopause and reporting bothersome symptoms in the
previous year for each symptom item. Across the study period
morethanoneinthreeofthesewomenreportedtroublesleeping,
aches and pains in joints, or anxiety and depression (until age
52 years). As a noticeably higher prevalence for all items was
evident at age 47 compared with subsequent years, responses
atage47wereomittedfromthesubsequentlatentclassanalyses.
The prevalence of symptoms declined from age 48 to 54 years
for half of the items surveyed: breast tenderness, palpitations,
dizziness, skin crawling sensations, irritability, anxiety or
depression, tearfulness, forgetfulness, and frequent severe
headaches. Five symptoms showed an increased prevalence:
trouble sleeping, aches and pains in joints, hot flushes, vaginal
dryness, and difficulties with sexual intercourse. Other
symptoms showed no age related changes: pins and needles in
hands and feet, feelings of panic, cold or night sweats, skin
wrinkling, and frequency of passing urine.
Factor analysis at each year (see web extra appendix 1 on
bmj.com)showedthatindividualsymptomsconsistentlyloaded
on to the same factor and in the same order of loading across
all years. These four symptom groups were labelled as
psychological, comprising trouble sleeping, anxiety and
depression, tearfulness, irritability, feelings of panic, and
forgetfulness; somatic, comprising aches and pains in joints,
pins and needles in hands and feet, dizziness, palpitations, skin
crawlingsensations,frequentsevereheadache,breasttenderness,
andincreasedfrequencyofpassingurine;vasomotor,comprising
cold or night sweats and hot flushes; and sexual discomfort,
comprising difficulties with intercourse and vaginal dryness.
Thegroupsforpsychological,vasomotor,andsexualdiscomfort
symptoms had a high degree of internal consistency (Cronbach
α>0.8), whereas symptom items were not as clearly identified
as being in the somatic symptoms group (Cronbach α>0.66).
Troublesleepingcrossloadedontovasomotorsymptoms(factor
loading >0.3 for all years except at age 51), but was included
inthepsychologicalsymptomsgroupasitsfactorloadingswere
consistently higher for this group. The items for hair loss and
skin wrinkling had factor loadings of less than 0.3 and were
removed from the subsequent analysis.
Psychological symptoms
Forpsychologicalsymptomsbasedonage,latentclassanalysis
resulted in five profiles (fig 1⇓). Two out of three women
(n=405) had mild or moderate symptom profiles with an
essentially flat trajectory, whereas 10% of women (n=60) had
very severe symptoms throughout the study period. A further
13% (n=79), who had the “recovering severe” profile, had
moderate symptoms by the end of the study; conversely, the
remaining 10% of women (n=63) with the onset severe profile
started at moderate levels and reported increasingly severe
symptoms until age 52 years. When the analysis was repeated
relative to age at menopause rather than chronological age (fig
1), similar profiles were identified for the 65% of women
(n=394) with mild and moderate symptoms. Those with the
very severe profile then appeared to have a slight peak at the
start of postmenopause. The 14% of women (n=84) who had
the recovering severe profile showed a general decline until
three years after menopause, whereas those in the onset severe
profilestartedwithmoderatesymptomsthatincreasedtoapeak
in the first two years of postmenopause and declined back to
moderate levels at four years of postmenopause.
Somatic symptoms
The four profiles identified for the somatic symptom group
show a slight decline in prevalence from age 48 to 54 years (fig
2⇓). When the analysis was based on relation to age at
menopause, 18% of women (n=99) were categorised as having
the severe or very severe profiles, with symptoms prevalent
even in premenopause and persisting through the menopausal
transition (fig 2).
Vasomotor symptoms
Half of the women (n=343) had the mild profile for vasomotor
symptoms, whereas 10% (n=70) were classified as very severe,
withchronicbothersomesymptomsacrossmidlife(fig3⇓).The
remaining two profiles showed either diminishing symptoms
(earlysevereprofile)orincreasingsymptoms(moderateprofile)
until a peak at age 53 years.
When vasomotor symptoms were analysed relative to age at
menopause (fig 3), the profiles showed a much clearer relation
between the prevalence of vasomotor symptoms and the timing
of menopause. Almost half of the women (n=287) were
classified as having mild symptoms, although in this analysis
a slight peak occurred in the year after menopause. The 14% of
women(n=83)whohadtheearlysevereprofile,alreadyreported
bothersome vasomotor symptoms premenopause or three years
before menopause, with their symptoms peaking at menopause
and then declining steadily in postmenopause. For the 11% of
women (n=67) with the late severe profile, the prevalence of
bothersome symptoms increased noticeably during
perimenopausetoapeakintheyearaftermenopause.Asimilar
trajectory but with a lower severity occurred for the one in four
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RESEARCHwomen (n=155) who had the late moderate profile, except that
the decline in the postmenopausal years was more evident.
Sexual discomfort symptoms
Analyses for symptoms of sexual discomfort (fig 4⇓) showed
that most women (>70%) had the mild profile (no bothersome
symptoms).Forprofilesrelativetoageatmenopause,aminority
ofwomen(4%)wereclassifiedashavingtheverysevereprofile,
with bothersome symptoms throughout the menopausal
transition. Ten per cent of women (n=60) had the moderate
symptom profile, which declined generally through the
menopausal transition. The remaining 14% (n=85) were
classified in the late severe profile, reporting an increasing
prevalence of bothersome symptoms of sexual discomfort in
late perimenopause through to menopause, with the level of
severity persisting for at least four years into postmenopause.
Cross tabulation of these profiles showed that 78% of women
(n=224)withthemildvasomotorsymptomprofilealsohadmild
sexual discomfort, and nearly one in three (n=27) women with
late severe sexual discomfort also had late moderate vasomotor
symptoms. The latter result is consistent with the similar shape
of these two profiles, with both increasing to a peak around the
start of postmenopause. Taking all the symptom groups into
consideration,14%ofthewomen(n=81)hadthemildestprofile
for all four groupings.
Sociodemographic factors and health
behaviours
Women in the somatic and vasomotor symptom groups had
similar sociodemographic and health behaviour characteristics
to those of the total sample of 695 women (table 2⇓, P>0.05
from χ
2 analysis), except for smoking status, where smokers
were under-represented in the symptom groups: 108 (21%) v
174 (28%). Women of manual social class or whose father was
of the manual social class were more likely to be categorised
as having the severe or very severe symptoms profile than were
women from the other social classes; women with advanced
secondary or degree level educational qualifications were less
likely to have the severe or very severe somatic symptoms
profilethanwerewomenwithnoqualifications.Noassociation
was evident between somatic symptom profiles and body mass
index,physicalactivitylevel,orsmokingstatus.Forvasomotor
symptoms,womenofnon-manualsocialclass,withdegreelevel
educational qualifications, non-smokers, and those with a body
mass index ≥30 were less likely to have the late moderate or
late severe profiles. No associations were found between
psychological symptom profiles and sociodemographic factors
or health behaviours at age 43 years or earlier (results not
shown). Although 80% of the women were married, marital
statuswasnotassociatedwithanyoftheothersymptomgroups.
Forsexualdiscomfort,marriedwomenweremorelikelytohave
thesevereorlatesevereprofile(oddsratio2.4,95%confidence
interval 1.3 to 4.4) than were women of other martial status.
Discussion
In this longitudinal study of the symptoms reported by women
with natural menopause we identified four stable symptom
groups: psychological, somatic, vasomotor, and sexual
discomfort. We used latent class analysis to characterise the
experience of bothersome symptoms in terms of profiles for
each symptom group. The profiles for the somatic symptoms
groups had an essentially flat trajectory through midlife and
were labelled to reflect the range of bothersome symptoms
reported, from mild to very severe. Lower social class and
education level were linked with the severe and very severe
profiles for somatic symptoms.
When psychological, vasomotor, and sexual discomfort
symptoms were analysed relative to age at menopause, a clear
relation was observed with the menopausal transition for some
profiles. Although two thirds of women reported only mild or
moderatepsychologicalsymptoms,forthe10%ofwomenwith
the onset severe profile, symptoms increased to a peak in the
firstyearsofpostmenopausebeforedeclining.Womenwhohad
theearlysevereprofile(14%)forvasomotorsymptomsreported
symptoms increasing over the three years before menopause
followed by a noticeable decline during postmenopause. This
contrasts with the late severe profile (11%), where the peak
occurred in the first year of postmenopause and remained high
overthesubsequentthreeyears.Womenofahighersocialclass
andeducationallevel,non-smokers,andthosewithabodymass
index of 30 or more were less likely to have the most adverse
profiles for vasomotor symptoms. For sexual discomfort, the
late severe profile (14%) showed a steep increase in symptoms
leading up to the first year of postmenopause, then reached a
plateau for the next three years of postmenopause. The
associationbetweenmarriedwomenandthesevereprofilemay
reflect a greater awareness of bothersome symptoms of sexual
discomfortamongsuchwomen.Morethan1in10ofthewomen
(14%) were classified into the mildest profile for all four
symptom groups.
Strengths and limitations of the study
The strength of this study derives from the use of longitudinal
data for a wide range of symptoms reported by a large and well
established national birth cohort study that regularly surveyed
thewomenthroughmidlife.Manypreviousobservationalstudies
have been limited to cross sectional analysis, used mean values
for the prevalence of specific symptoms, or were restricted to
clinicbasedsamples.Withourapproachofusingfactoranalysis
and latent class analysis, we were able to identify the grouping
of symptoms and their variation through midlife. This is an
exploratory technique, in that it is data driven and does not
assumeapriorisymptomgroupings.Confidenceinthesymptom
groupings identified here, however, is strengthened by the
confirmatory analysis that indicated their stability over time.
The innovative aspect has been to develop profiles based on
age relative to menopause rather than chronological age, which
permits a more detailed characterisation of symptom profiles
and their relation to the menopausal transition.
Althoughonlydatafromthosewomenwhoexperiencednatural
menopausewereusedinthisstudy,itwasstillpossibleforthem
to have had hormone therapy at least two years before
menopause or during postmenopause. This was the case,
however, only for a minority of women (n=13), and their data
donotaffecttheidentifiedsymptomprofiles.Thelinksbetween
some sociodemographic factors and health behaviours and
bothersome symptoms may result from the differential attrition
of the women with hysterectomy or those taking hormone
treatment who were excluded from the analyses. Stronger
relations may exist between symptom profiles and
contemporaneous measures of sociodemographic and health
behaviours (rather than baseline measures at age 43 years). All
thesymptomsarereportedandtherearenobiomarkers.Itisthe
perception of symptoms, however, that may prompt women to
visit health professionals.
Repeatingtheanalysisincludingthe20womenwithincomplete
responses to questions on symptoms left the results unchanged.
Eighty three of the 695 women with natural menopause for
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RESEARCHwhom age at menopause could not be determined were thus not
included in the analysis for symptom profiles with respect to
age at menopause. The women in this analysis, however, had
similar sociodemographic factors and health behaviour
characteristics except for the proportion of smokers in the
sample whose age at menopause was lower.
Unlike the analysis of symptoms based on age, for the profiles
at four or more years postmenopause, data on symptoms were
available for 335 (56%) of the women. This means there may
bemarginallylessresolutionattheendoftheanalysis,although
the main interpretation of findings is based on general
characteristicsorshapeoftheprofile,suchasaprogressiveyear
on year decline in symptoms.
We did not exclude women with acute or chronic health
conditions or those receiving drugs, which could potentially
confoundtheresults,suchastheuseofantidepressantsmasking
vasomotor symptoms. Their effects, however, would have to
alter the characteristics or shape of profiles to substantively
affect the main findings.
The prevalence of bothersome symptoms reported at age 47
yearswashigherthaninsubsequentsurveys,whichmaybedue
to a “telescoping” effect because women were asked to report
their symptoms for the first time. In the latent class analysis we
omitteddataonsymptomsfromthefirstyeartoidentifyprofiles.
Annual surveys also limit the ability to resolve the timing of
eventssuchasmenopausewithrespecttochangesinsymptoms
overanarrowertimewindow,andthelengthofrecallmayaffect
the reporting of the severity of symptoms.
Comparison with other studies
This study draws on symptoms reported during midlife for a
cohort of women born in Britain in 1946 and experiencing a
naturalmenopause;neverthelessthesymptomgroups—somatic,
psychological, vasomotor, and sexual discomfort—essentially
match those in previous findings from key studies.
16 17 Latent
class analysis was also recently used to identify similar clusters
of symptoms in a small study of 103 women,
18 but not to
determine symptom profiles over time. Our finding that only a
minority of women in the psychological symptom group have
symptom profiles that seem related to the timing of the
menopausal transition is consistent with the National Institutes
of Health consensus statement that finds only limited or weak
evidenceforalinkbetweenthemenopauseandmoodsymptoms
and cognitive disturbances, although they identify moderate
evidenceofalinkwithsleepdisturbances.
3Ourstudyaddsvalue
by showing that only a minority of women have psychological
symptomsrelatedtothemenopausaltransition.Thismayexplain
why evidence from previous studies that took a variable rather
than person centred approach may have been inconsistent,
especially the contrast between clinic based and population
samples.
3 Similarly, the profiles of somatic symptoms are
consistent with most studies that have found no association
betweenmenopausalstatusandsomaticsymptoms,suchasstiff
or painful joints. Only the late severe profile for sexual
discomfort (14% of the women) seems to be clearly linked to
the timing of menopause, which nevertheless is consistent with
the consensus view that the prevalence of vaginal dryness
increases across the menopausal transition.
3 19
The association between vasomotor symptoms and the
menopause is also well established, but this study adds value
bydistinguishinganearlysevereaswellasalatesevereprofile.
In a recent review, the authors found that the prevalence of hot
flushes varies across menopausal stages, with premenopausal
women reporting hot flushes at a far lower although clinically
significant rate (median of reported rates was 21.5%) than did
perimenopausal or postmenopausal women.
1 6 This compares
with the 14% of women who were classified in the early severe
profile, characterised by the prevalence of bothersome
vasomotor symptoms even three years before menopause. Our
result thatobesewomentend nottobeclassifiedwithmoderate
or late severe vasomotor symptom profiles is consistent with
the known conversion of androgens to oestrogens in body fat.
20
Thiscontrastswithfindingsfromotherlongitudinalstudiesthat
show higher adiposity associated with reporting of vasomotor
symptoms,
21 22 although the results from these studies are not
strictly comparable owing to the different analytical methods
used.
Implications of findings
The symptom profiles identified in this research provide a
picture of the variation of symptoms, including any effects of
treatments or management strategies, reported by this cohort of
women with natural menopause. The findings represent a next
step—most notably with the profiles for psychological,
vasomotor,andsexualdiscomfortsymptoms—thatifconfirmed
inotherstudiesandpopulationscanprovidehealthprofessionals
with information to support a more tailored approach to advice
and treatment for women. It should be stressed that the
classificationofsymptomsaccordingtoprofilesisprobabilistic,
representing the likelihood of a woman following one or other
profile.Theyshouldbeusedonlyasageneralguide,ratherthan
for individual prediction, as to the possible trajectory of
symptoms in terms of characteristics such as peaks before or
aftermenopauseandwhensymptomstendtodeclineorplateau.
In practice, a key limitation for profiles based on age relative
to menopause lies in the uncertainty of premenopausal and
perimenopausal women in knowing at the time of consultation
when menopause will occur. Nevertheless, women whose
symptoms follow a particular profile may find that the
information facilitates decisions on the management of
symptoms or the timing of treatment options. Even the
understanding for many that their somatic or psychological
symptoms are likely to persist through midlife, may alleviate a
woman’s concerns about the prospect of symptoms worsening
through the menopausal transition. The 10% of women whose
psychological symptoms increase from moderate levels during
perimenopause(onsetsevereprofile),canbereassuredthattheir
symptoms are likely to decline from early postmenopause back
to moderate levels.
Once such profiles are established, key points where they
divergecanpotentiallyallowhealthprofessionalstodistinguish
the most likely profile that will characterise an individual
woman’s symptoms. The profiles here suggest that
perimenopausalwomenwithbothersomevasomotorsymptoms
dating back several years (the early severe profile) are likely to
experience an increase in severity until menopause. The
subsequentdeclineinprevalenceofsymptomsinpostmenopause
may mean that some women would decide management
strategiesaresufficient.Womenwiththelatesevereprofilecan
expect bothersome vasomotor symptoms to last for more than
five years in postmenopause; similarly, for women with the
severe profile for sexual discomfort. Both types of women
present a dilemma for health professionals, since bothersome
symptoms are likely to last longer than the duration that is
considered desirable for the prescription of hormone treatment.
In both cases women may decide that long term management
of symptoms is a better option. In contrast, for women with the
late moderate profile of vasomotor symptoms, hormone
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RESEARCHtreatment for a short period may provide an effective option for
alleviating symptoms during the peak in early postmenopause.
Conclusions
Thisstudypresentsapictureofreportedsymptomsfromacohort
of women with natural menopause. Longitudinal symptom
profiles represent a step forward from standard statistics that
describe symptoms during menopause in terms such as average
prevalence or duration. These profiles illustrate the different
levels of symptom severity and how these track over time,
especially in relation to menopause. The approach should be
replicated in studies on other populations and cultures, as
thresholds for reporting symptoms during midlife may differ.
Further research is needed to investigate factors that may affect
profiles, including current health status and drug use as well as
the symptom profiles of women who have not had a natural
menopause. Researchers should also examine the relation
betweensymptomprofilesandlongtermhealthoutcomes,such
astheriskofcardiovasculardisease.Symptomprofilesprovide
a useful way to translate results from longitudinal studies; over
time they may develop as a guidance tool for health
professionals.
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RESEARCHWhat is already known on this topic
Only a few symptoms reported by women during midlife have established links with the menopausal transition
Many studies on links between symptoms and menopause report mixed findings, are cross sectional or clinic based, and typically report
the prevalence of symptoms as mean value
Little is known about the timing or variation in the severity of symptoms or if subgroups of women exist with similar symptom profiles or
trajectories through the menopausal transition
What this study adds
Four groups of symptoms were identified in women with natural menopause: psychological, somatic, vasomotor, and sexual discomfort
Some profiles for psychological and vasomotor symptoms and sexual discomfort showed a clear relation to the menopausal transition
Symptom profiles can assist health professionals to tailor their advice for women about the likely severity and duration of their symptoms
during menopause
Tables
Table 1| Numbers (percentages) of women who reached natural menopause by age 54 years and symptoms experienced during midlife
(n=695 women)
P values Age (years) Symptoms
54 53 52 51 50 49 48 47
<0.001 312 (44.9) 305 (43.9) 320 (46.1) 305 (43.9) 291 (41.9) 265 (38.1) 250 (36.0) 332 (47.7) Trouble sleeping
0.005 322 (46.4) 334 (48.1) 318 (45.7) 318 (45.7) 312 (44.9) 308 (44.3) 281 (40.5) 385 (55.4) Aches and pains in joints
<0.001 59 (8.5) 72 (10.4) 93 (13.4) 111 (16.0) 115 (16.6) 149 (21.4) 161 (23.1) 273 (39.3) Breast tenderness
0.04 235 (33.8) 235 (33.8) 245 (35.2) 224 (32.3) 223 (32.1) 231 (33.3) 192 (27.6) 221 (31.8) Hot flushes
0.007 96 (13.8) 94 (13.5) 101 (14.5) 109 (15.7) 102 (14.7) 114 (16.4) 120 (17.2) 184 (26.5) Palpitations
0.05 87 (12.5) 95 (13.6) 98 (14.1) 112 (16.1) 107 (15.4) 97 (14.0) 113 (16.2) 168 (24.2) Dizziness
0.16 73 (10.5) 90 (12.9) 85 (12.2) 92 (13.2) 100 (14.4) 87 (12.5) 94 (13.5) 161 (23.1) Pins and needles in hands and feet
0.05 57 (8.2) 56 (8.0) 76 (11.0) 59 (8.5) 78 (11.3) 73 (10.5) 74 (10.7) 91 (13.1) Skin crawling sensations
<0.001 164 (23.6) 198 (28.5) 177 (25.5) 191 (27.5) 216 (31.1) 226 (32.5) 238 (34.3) 348 (50.1) Irritability
<0.001 202 (29.0) 222 (32) 240 (34.6) 237 (34.1) 245 (35.3) 257 (37) 258 (37.1) 340 (48.9) Anxiety and depression
0.003 145 (20.8) 159 (22.9) 174 (25.1) 154 (22.1) 168 (24.2) 175 (25.2) 191 (27.5) 256 (36.8) Tearfulness
0.3 113 (16.2) 103 (14.8) 122 (17.6) 104 (15) 115 (16.6) 119 (17.1) 120 (17.2) 152 (21.8) Feelings of panic
0.009 202 (29.0) 199 (28.7) 211 (30.4) 213 (30.7) 224 (32.3) 218 (31.3) 232 (33.4) 287 (41.3) Forgetfulness
0.5 38 (5.4) 36 (5.2) 40 (5.7) 42 (6.1) 28 (4.0) 34 (4.9) 35 (5.1) 48 (6.9) Hair loss
0.8 132 (19.0) 140 (20.2) 173 (24.9) 158 (22.7) 158 (22.7) 147 (21.1) 141 (20.3) 177 (25.4) Cold or night sweats
0.16 93 (13.4) 81 (11.6) 79 (11.3) 73 (10.5) 70 (10.1) 74 (10.6) 83 (12.0) 111 (15.9) Skin wrinkling
<0.001 125 (18.0) 129 (18.5) 124 (17.9) 117 (16.8) 98 (14.1) 107 (15.4) 83 (12.0) 136 (19.6) Vaginal dryness
<0.001 115 (16.6) 114 (16.4) 110 (15.8) 90 (12.9) 81 (11.6) 77 (11.1) 67 (9.6) 83 (11.9) Difficulties with sexual intercourse
0.2 136 (19.5) 124 (17.9) 137 (19.7) 133 (19.1) 113 (16.2) 122 (17.6) 120 (17.2) 147 (21.2) Increased frequency of passing urine
<0.001 79 (11.3) 97 (14.0) 99 (14.3) 115 (16.6) 126 (18.2) 124 (17.9) 147 (21.1) 190 (27.4) Frequent severe headache
*Symptoms that bothered participants a little and a lot in previous 12 months.
†Test of trend using data from women aged 48 to 54 years.
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RESEARCHTable 2| Sociodemographic factors and lifestyle characteristics by profiles of somatic and vasomotor symptoms relative to age at menopause
P
value
Odds ratio
(95% CI) ‡
Profiles of vasomotor symptoms
P
value
Odds ratio
(95% CI)‡
Profiles of somatic symptoms
No
(n=592)†
No (%)
(n=695)* Characteristics
Late
moderate/late
severe
Early
severe Mild
Severe/very
severe Moderate Mild
0.17 0.002 Childhood social
class:
— Reference 40.7 14.6 44.6 — Reference 23.2 38.6 38.2 280 375 (57) Manual
0.17 0.79 (0.57 to
1.01)
35.5 13.8 50.5 0.002 0.60 (0.44 to
0.84)
11.7 40.6 47.7 239 281 (43) Non-manual
0.02 0.03 Own social class:
— Reference 43.4 18.9 37.7 — Reference 24.6 38.5 36.9 122 171 (25) Manual
0.02 0.65 (0.92 to
0.95)
35.8 13.1 51.1 0.03 0.65 (0.44 to
0.96)
15.8 38.9 45.3 411 506 (75) Non-manual
0.02 0.03 Education
qualification:
— Reference 41.5 15.8 42.7 — Reference 23.4 38.6 38.0 171 237 (36) None
0.8 0.95 (0.64 to
1.42)
41.7 13.3 45.0 0.3 0.82 (0.55 to
1.21)
21.1 35.6 43.3 180 222 (33) Lower
secondary
0.07 0.68 (0.44 to
1.04)
32.8 14.2 53.0 0.01 0.54 (0.36 to
0.84)
6.7 45.5 47.8 134 163 (25) Advanced
secondary
0.008 0.37 (0.18 to
0.77)
19.4 13.9 66.8 0.08 0.55 (0.28 to
1.08)
11.1 38.9 50.0 36 40 (6) Degree
0.07 0.3 Body mass index:
— Reference 39.1 16.7 44.2 — Reference 15.9 39.1 44.9 276 358 (56) 20-24.9
0.5 1.22 (0.66 to
2.29)
45.0 15.0 40.0 0.6 1.19 (0.64 to
2.20)
17.5 42.5 40.0 40 54 (9) <20
0.16 0.75 (0.50 to
1.13)
34.2 13.0 52.9 0.4 1.17 (0.79 to
1.73)
18.7 39.8 41.5 123 144 (23) 25-29.9
0.03 0.54 (0.30 to
0.94)
30.5 6.8 62.7 0.06 1.65 (0.97 to
2.83)
27.1 37.3 35.6 59 79 (12) >30
0.2 0.3 Vigorous activity:
— Reference 38.4 14.9 46.6 — Reference 20.2 39.6 40.3 268 349 (55) Inactive
0.13 0.73 (0.48 to
1.09)
31.1 14.3 54.6 0.31 0.81 (0.54 to
1.22)
13.5 43.7 42.9 119 150 (23) At least once a
week
0.7 1.08 (0.71 to
1.63)
41.4 12.9 45.7 0.13 0.73 (0.48 to
1.09)
17.2 33.6 49.1 116 142 (22) More than once
a week
0.02 0.3 Smoking status:
Reference 46.3 14.8 38.9 — Reference 20.4 40.7 38.9 108 174 (27) Current smoker
0.02 0.61 (0.41 to
0.92)
34.8 14.2 51.0 0.3 0.81 (0.54 to
6.3)
17.3 38.6 44.2 394 466 (73) Non-smoker
*Women with natural menopause.
†Women with age at menopause available and who contributed to analysis of symptom profiles relative to age at menopause: mean age at menopause 49.5 (SD
3.5) years.
‡Results from multinomial logistic regression modelling odds of having more severe symptoms profile.
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Fig 1 Profiles of psychological symptoms across midlife and according to age relative to menopause
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RESEARCHFig 2 Profiles of somatic symptoms across midlife and according to age relative to menopause
Fig 3 Profiles of vasomotor symptoms across midlife and according to age relative to menopause
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RESEARCHFig 4 Profiles of sexual discomfort symptoms across midlife and according to age relative to menopause
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